...
search icon
mrvi-img

Maravai Lifesciences Holdings Inc, Common Stock

MRVI

NSQ

$2.22

-$0.07

(-3.05%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$302.35M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.24M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.19
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.67 L
$11.16 H
$2.22

About Maravai Lifesciences Holdings Inc, Common Stock

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameMRVISectorS&P500
1-Week Return5.71%-1.91%-1.87%
1-Month Return5.71%-3.82%8.93%
3-Month Return-44.64%-11.56%-2.39%
6-Month Return-58.03%-10.21%-2.41%
1-Year Return-79.41%-9.91%10.88%
3-Year Return-93.78%-0.28%46.93%
5-Year Return-92.56%31.29%94.89%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue284.10M799.24M883.00M288.94M259.19M[{"date":"2020-12-31","value":32.17,"profit":true},{"date":"2021-12-31","value":90.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.72,"profit":true},{"date":"2024-12-31","value":29.35,"profit":true}]
Cost of Revenue79.65M140.56M168.96M148.74M150.88M[{"date":"2020-12-31","value":47.14,"profit":true},{"date":"2021-12-31","value":83.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.04,"profit":true},{"date":"2024-12-31","value":89.3,"profit":true}]
Gross Profit204.45M658.68M714.04M140.20M108.31M[{"date":"2020-12-31","value":28.63,"profit":true},{"date":"2021-12-31","value":92.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":19.63,"profit":true},{"date":"2024-12-31","value":15.17,"profit":true}]
Gross Margin71.96%82.41%80.87%48.52%41.79%[{"date":"2020-12-31","value":87.32,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.12,"profit":true},{"date":"2023-12-31","value":58.88,"profit":true},{"date":"2024-12-31","value":50.71,"profit":true}]
Operating Expenses103.55M115.28M147.63M171.85M343.93M[{"date":"2020-12-31","value":30.11,"profit":true},{"date":"2021-12-31","value":33.52,"profit":true},{"date":"2022-12-31","value":42.92,"profit":true},{"date":"2023-12-31","value":49.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income67.60M554.64M574.22M(31.65M)(235.62M)[{"date":"2020-12-31","value":11.77,"profit":true},{"date":"2021-12-31","value":96.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.51,"profit":false},{"date":"2024-12-31","value":-41.03,"profit":false}]
Total Non-Operating Income/Expense(52.83M)(54.14M)(40.82M)631.32M(46.16M)[{"date":"2020-12-31","value":-8.37,"profit":false},{"date":"2021-12-31","value":-8.58,"profit":false},{"date":"2022-12-31","value":-6.47,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-7.31,"profit":false}]
Pre-Tax Income81.70M530.76M551.47M617.74M(261.48M)[{"date":"2020-12-31","value":13.23,"profit":true},{"date":"2021-12-31","value":85.92,"profit":true},{"date":"2022-12-31","value":89.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-42.33,"profit":false}]
Income Taxes2.88M61.52M60.81M756.11M(1.86M)[{"date":"2020-12-31","value":0.38,"profit":true},{"date":"2021-12-31","value":8.14,"profit":true},{"date":"2022-12-31","value":8.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-0.25,"profit":false}]
Income After Taxes78.82M469.25M490.66M(138.38M)(259.62M)[{"date":"2020-12-31","value":16.06,"profit":true},{"date":"2021-12-31","value":95.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-28.2,"profit":false},{"date":"2024-12-31","value":-52.91,"profit":false}]
Income From Continuous Operations78.82M469.25M490.66M59.04M(259.62M)[{"date":"2020-12-31","value":16.06,"profit":true},{"date":"2021-12-31","value":95.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":12.03,"profit":true},{"date":"2024-12-31","value":-52.91,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income76.89M469.25M490.66M(119.03M)(144.85M)[{"date":"2020-12-31","value":15.67,"profit":true},{"date":"2021-12-31","value":95.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-24.26,"profit":false},{"date":"2024-12-31","value":-29.52,"profit":false}]
EPS (Diluted)0.111.591.80(0.02)(0.16)[{"date":"2020-12-31","value":6.11,"profit":true},{"date":"2021-12-31","value":88.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.11,"profit":false},{"date":"2024-12-31","value":-8.66,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MRVI
Cash Ratio 4.51
Current Ratio 5.96
Quick Ratio 5.17

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MRVI
ROA (LTM) -4.64%
ROE (LTM) -44.32%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MRVI
Debt Ratio Lower is generally better. Negative is bad. 0.45
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.31

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MRVI
Trailing PE NM
Forward PE 370.37
P/S (TTM) 3.47
P/B 1.10
Price/FCF NM
EV/R 1.72
EV/Ebitda 1.77

FAQs

What is Maravai Lifesciences Holdings Inc share price today?

Maravai Lifesciences Holdings Inc (MRVI) share price today is $2.22

Can Indians buy Maravai Lifesciences Holdings Inc shares?

Yes, Indians can buy shares of Maravai Lifesciences Holdings Inc (MRVI) on Vested. To buy Maravai Lifesciences Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MRVI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Maravai Lifesciences Holdings Inc be purchased?

Yes, you can purchase fractional shares of Maravai Lifesciences Holdings Inc (MRVI) via the Vested app. You can start investing in Maravai Lifesciences Holdings Inc (MRVI) with a minimum investment of $1.

How to invest in Maravai Lifesciences Holdings Inc shares from India?

You can invest in shares of Maravai Lifesciences Holdings Inc (MRVI) via Vested in three simple steps:

  • Click on Sign Up or Invest in MRVI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Maravai Lifesciences Holdings Inc shares
What is Maravai Lifesciences Holdings Inc 52-week high and low stock price?

The 52-week high price of Maravai Lifesciences Holdings Inc (MRVI) is $11.16. The 52-week low price of Maravai Lifesciences Holdings Inc (MRVI) is $1.67.

What is Maravai Lifesciences Holdings Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Maravai Lifesciences Holdings Inc (MRVI) is 1.10

What is the Market Cap of Maravai Lifesciences Holdings Inc?

The market capitalization of Maravai Lifesciences Holdings Inc (MRVI) is $302.35M

What is Maravai Lifesciences Holdings Inc’s stock symbol?

The stock symbol (or ticker) of Maravai Lifesciences Holdings Inc is MRVI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top